BioSpace News Archive

Creative picture image collage banner of guy worker jump from financial charts determined company success.

Rare diseases

Argenx Eyes ‘Broadest Label’ for Vyvgart in Myasthenia Gravis After Positive Phase III Data

Based on new data, argenx expects to file for the expansion of Vyvgart’s label into patients with generalized myasthenia gravis who are negative for antibodies against the AChR marker—an indication William Blair analysts called the broadest option in this disease space.

August 26, 2025

·

2 min read

·

Tristan Manalac

Pictured: CDC signage at its headquarters in Georg

COVID-19

CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup

The MIT professor of management, who already sits on the CDC’s revamped immunization advisory committee, is a known skeptic of vaccines, particularly mRNA technology.

August 26, 2025

·

2 min read

·

Tristan Manalac

Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VII

Obesity

Lilly Plots Path to FDA After Second Phase III Readout for Orforglipron

While Truist Securities analysts said the results from the ATTAIN-2 trial leave “room for competition,” they also pointed to a manufacturing advantage that could unlock a “double-digit billion dollar opportunity” for Eli Lilly.

August 26, 2025

·

2 min read

·

Tristan Manalac

Press Releases

Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

August 26, 2025

·

5 min read

Press Releases

New Three-Phase Course from PumasAI and SOPHAS on AI in Drug Development Set to Launch this October